Graves' disease in children: Clinical aspects and outcome;Maladie de Basedow chez l'enfant: Aspects cliniques et evolutifs

Archives de Pediatrie

Volumn 5, Issue 7, 1998, Pages 722-730

  Boiko, J ^a   Leger J ^a   Raux Demay, M C ^b   Cabrol, S ^b   Le Bouc, Y ^b   Czernichow, P ^b  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b ARMAND TROUSSEAU HOSPITAL   (France)

Author keywords

Child; Follow up studies; Graves' disease; Thyroid antagonist

Indexed keywords

ANTITHYROID AGENT;

ADOLESCENT; ARTICLE; AUTOIMMUNITY; CHILD; FAMILY HISTORY; FEMALE; FOLLOW UP; GOITER; GRAVES DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTHYROIDISM; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; SURVIVAL RATE; TACHYCARDIA; TREATMENT OUTCOME;

EID: 0032127392     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-693X(98)80052-3     Document Type: Article

References (35)

1. 1 Vaidya VA, Bongiovanni AM, Parks JS, Tenore A, Kirkland RT. Twenty-two years' experience in the medical management of juvenile thyrotoxicosis. Pediatrics 1974 ; 54 : 565-70
2. 2 Lippe BM, Landaw EM, Kaplan SA. Hyperthyroidism in children treated with long term medical therapy: twenty-five percent remission every 2 years. J Clin Endocrinol Metab 1987 ; 64: 1241-5
3. 3 Gorton C, Sadeghi-Nejad A, Senior B. Remission in children with hyperthyroidism treated with propylthiouracil. Long term results. Am J Dis Child 1987 ; 141 : 1084-6
4. 4 Barnes HV, Blizzard RM. Antithyroid drug therapy for toxic diffuse goiter (Graves' disease): thirty years experience in children and adolescents. J Pediatr 1977 ; 91 ; 2 : 313-20
5. 5 Hamburger JI. Management of hyperthyroidism in children and adolescents. J Clin Endocrinol Metab 1985 ; 60 : 1019-24
6. 6 Glaser NS, Styne DM. Predictors of early remission of hyperthyroidism in children. J Clin Endocrinol Metab 1997 ; 82 : 1719-26
7. 7 Zimmerman D, Gan-Gaisano M. Hyperthyroidism in children and adolescents. Pediatr Clin North Am 1990 ; 37 : 1273-95
8. 8 Thibault H, Clausse-Moysoulier D, Brauner R. Traitement de l'hyperthyroïdie de l'enfant par les antithyroïdiens. Ann Pédiatr (Paris) 1993 ; 40 : 341-7
9. 9 Allannic H, Fauchet R, Orgiazzi J, Madec AM, Genetet B, Lorcy V et al. Antithyroid drugs and Graves' disease: a prospective randomized evaluation of the efficacy of treatment duration. J Clin Endocrinol Metab 1990 ; 70 : 675-9
10. 10 Franklyn JA. The management of hyperthyroidism. N Engl J Med 1994; 330: 1731-8
11. 11 Cooper DS. Antithyroid drugs. N Engl J Med 1984 ; 311 : 1353-62
12. 12 Lazarus JH. Hyperthyroidism. Lancet 1997 ; 349 : 339-43
13. 13 David M, Jaubert de Beaujeu M, De Haas P, Morel Y, Augay C, Loras B et al. Traitement de la maladie de Basedow chez l'enfant. À propos de 24 observations. Lyon Méd 1983 ; 250 ; 13 : 49-54
14. 14 Sempé M, Pedron G, Roy MP. Auxologie, méthodes et séquences. Paris : Theraplix ; 1979. p 205
15. 15 Tanner JM, Hiernaux J, Jarman S. Growth and physique studies. In: Weiner JS, Laurie JA, eds. Human Biology: a Guide to Field Methods. Oxford: Blackwell Scientific Publications; 1969
16. 16 Greulich WW, Pyle SI. Radiographic Atlas of Skeletal Developement of the Hand and Wrist. 2nd ed. Stanford: Stanford University Press; 1959
17. 17 Ruiz JC, Mandel C, Garabedian M. Influence of spontaneous calcium intake and physical exercise on the vertebral and femoral bone mineral density of children and adolescent. J Bone Miner Res 1995 ; 10 : 675-82
18. 18 Romaldini JH, Bromberg N, Werner RS, Tanaka LM, Rodrigues HF, Werner MC et al. Comparison of effects of high and low dosage regimens of antithyroid drugs in the management of Graves' hyperthyroidism. J Clin Endocrinol Metab 1983 ; 57 : 563-70
19. 19 Reinwein D, Benker G, Lazarus JN, Alexander WD. A prospective randomized trial of antithyroid drug dose in Graves' disease therapy. European Multicenter Study Group on Antithyroid Drug Treatment. J Clin Endocrinol Metab 1993 ; 76 : 1516-21
20. 20 Buckler JMH, Willgerodt H, Keller E. Growth in thyrotoxicosis. Arch Dis Child 1986 ; 61 : 464-71
21. 21 Collen RJ, Landaw EM, Kaplan SA, Lippe BM. Remission rates of children and adolescents with thyrotoxicosis treated with antithyroid drugs. Pediatrics 1980 ; 65 : 550-6
22. 22 Léger J, Thizon de Gaulle I, Czernichow P. Déminéralisation osseuse et élévation des concentrations sériques d'ostéocalcine chez les jeunes enfants atteints d'hyperthyroïdie. Ann Pédiatr (Paris) 1993 ; 40 :404-9
23. 23 Léger J, Czernichow P, Garabédian M, Brauner R, Rappaport R. Ostéopénie grave chez de jeunes enfants atteints d'hyperthyroïdie. Deux observations. Arch Fr Pédiatr 1986 ; 43 ; 123-5
24. 24 Wakasugi M, Wakao R, Tawata M, Gan N, Koizumi K, Onaya T. Bone mineral density in patients with hyperthyroidism measured by dual energy X-ray absorptiometry. Clin Endocrinol 1993 ; 38 : 283-6
25. 25 Léger J, Czernichow P. Troubles du métabolisme phosphocalcique et osseux au cours des affections thyroïdiennes. In : Garabedian M, Dumas R, David D, Mallet E, eds. Métabolisme phosphocalcique normal et pathologique chez l'enfant. Paris : Flammarion Médecine-Sciences ; 1995. p 131-6
26. 26 Hashizume K, Ichikawa K, Sakurai A, Suzuki S, Takeda T, Kobayashi M et al. Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism. N Engt J Med 1991 ; 324 : 947-53
27. 27 McIver B, Rae P, Beckett G, Wilkinson E, Gold A, Toft A. Lack of effect of thyroxine in patients with Graves' hyperthyroidism who are treated with an antithyroid drug. N Engl J Med 1996 ; 334 : 220-4
28. 28 Rittmaster RS, Zwicker H, Abbott EC, Givner ML, Lehmann L, Reddy S et al. Effect of methimazole with or without exogenous L-thyroxine on serum concentrations of thyrotropin (TSH) receptor antibodies in patients with Graves' disease. J Clin Endocrinol Metab 1996 ; 81 : 3283-8
29. 29 Tamai H, Hayaki I, Kawai K, Komaki G, Matsubayashi S, Kuma K et al. Lack of effect of thyroxine administration on elevated thyroid stimulating hormone receptor antibody levels in treated Graves' disease patients. J Clin Endocrinol Metab 1995 ; 80 : 1481-4
30. 30 Lucas A, Salinas I, Rius F, Pizarro E, Granada ML, Foz M et al. Medical therapy of Graves' disease: does thyroxine prevent recurrence of hyperthyroidism? J Clin Endocrinol Metab 1997 ; 82 : 2410-3
31. 31 Perrild H, Grüters-Kieslich A, Feldt-Rasmussen U, Grant D, Martino E, Kayser L et al. Diagnosis and treatment of thyrotoxicosis in childhood. A European questionnaire study. Eur J Endocrinol 1994 ; 131 : 467-73
32. 32 Clark JD, Gelfand MJ, Elgazzar AH. Iodine-131 therapy of hyperthyroidism in pediatric patients. J Nucl Med 1994 ; 36 : 442-5
33. 33 Foley TP, White C, New A. Juvenile Graves' disease: usefulness and limitations of thyrotropin receptor antibody determinations. J Pediatr 1987 ; 110 : 378-86
34. 34 Törring O, Tallstedt L, Wallin G, Lundell G, Ljunggren JG, Taube A et al. Graves' hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine - a prospective, randomized study. J Clin Endocrinol Metab 1996 ; 81 : 2986-93
35. 35 Franklyn JA, Daykin J, Drolc Z, Farmer M, Sheppard MC. Long-term follow-up of treatment of thyrotoxicosis by three different methods. Clin Endocrinol (Oxf) 1991 ; 34 : 71-6